The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Kaygee Investments Pvt Ltd & PACs
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kaygee Investments Pvt Ltd (KIPL), the promoter of Makers Laboratories, has disclosed a change in shareholding resulting from the merger of its two wholly-owned subsidiaries — Paschim Chemicals Pvt Ltd (PCPL) and Mexin Medicaments Pvt Ltd (MMPL) — into KIPL itself, pursuant to an order by the Regional Director (WR) Mumbai under Section 233 of the Companies Act, 2013. As a result, the 16.38% stake previously held by PCPL and the 3.12% stake previously held by MMPL in Makers Laboratories have now vested directly in KIPL. KIPL's direct holding has therefore increased from 19.50% (11,50,579 shares) to 36.88% (21,75,859 shares), while PCPL and MMPL now hold nil. The total promoter group holding in Makers Laboratories remains unchanged at 36.88%. The effective date of the acquisition is August 20, 2025, and the mode is described as an inter-se transfer pursuant to the merger order.
This is a purely internal restructuring within the promoter group — there is no change in the total promoter/promoter group stake (still 36.88%), no fresh buying from the market, and no change in control. Retail shareholders are not affected and there should be no material impact on the stock price from this disclosure alone.